HOSTILE ENVIRONMENTS PROMOTE INVASION AND METATASIS

恶劣的环境促进入侵和转移

基本信息

  • 批准号:
    7122461
  • 负责人:
  • 金额:
    $ 28.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-07-01 至 2009-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In this competitive renewal application, we continue to maintain our focus on breast cancer invasion and metastasis. Metastatic breast cancer has pitifully low survival rates, and the challenge of our decade continues to be to find ways to prevent cancer cells from disseminating. With the past four years we made key observations, which have led us to focus on understanding the role of cyclooxygenase-1 and -2 in breast cancer invasion and metastasis. The first was that the anti-inflammatory nonspecific COX inhibitor, indomethacin, significantly reduced breast cancer cell invasion. We also found that the choline phospholipid metabolism of invasive breast cancer cells treated with indomethacin reverted towards a choline phospholipid phenotype more typical of a nonmalignant cell line. Additionally, we observed an increased expression of COX-1 with malignant progression. These observations have led us to formulate three new hypotheses: (1) Phosphocholine and vascular volume and permeability detected by MRS and MRI will be higher in COX-1 and COX-2 overexpressing cells and solid tumors compared to wild type or vector transfected control cells and tumors. Increased expression of COX-1 and COX-2 will result in an increase in invasion and metastasis; (2) Decreased COX-1 and COX-2 will decrease invasion and metastasis. A decrease in phosphocholine and vascular volume and permeability will be detected in the MRS and MRI studies of cells and solid tumors; (3) Cancer cells secrete paracrine factors which may primarily be derived from cyclooxygenase activity which significantly alter endothelial cell-cancer cell interactions and play a significant role in promoting invasion and metastasis from inflammation inducing conditions in solid tumors. In this competitive renewal application we will use state of the art noninvasive magnetic resonance (MR) imaging (I) and spectroscopy (S) methods, and molecular biology approaches utilizing siRNA technology to test these hypotheses. The cyclooxygenase enzymes COX-1 and -2 synthesize PGs from arachidonic acid. Prostaglandins (PGs) produced by tumor cells or tumor-associated host cells such as macrophages, endothelial cells and stromal cells have long been known to play a stimulating role in progression and metatases of animal and human tumors. The studies proposed in this application will lead to the potential identification of targets and pathways for the prevention of metastatic disease.
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Zaver M. Bhujwalla其他文献

Low-dose temozolomide selectively increases glioblastoma’s vascular permeability, tumor microenvironment penetration and the killing potential of systemic actinium-225 α-particle dendrimer-radioconjugates improving treatment efficacy
  • DOI:
    10.1007/s00259-025-07332-w
  • 发表时间:
    2025-05-14
  • 期刊:
  • 影响因子:
    7.600
  • 作者:
    Rajiv Ranjit Nair;Aira Sarkar;Pooja Hariharan;Kathleen L. Gabrielson;Tony Wu;Chang Liu;Anjali Sharma;Wathsala Liyanage;Zaver M. Bhujwalla;Marie-France Penet Vidaver;Rangaramanujam M. Kannan;Stavroula Sofou
  • 通讯作者:
    Stavroula Sofou
Artificial neural network detection of pancreatic cancer from proton (1H) magnetic resonance spectroscopy patterns of plasma metabolites
基于血浆代谢物质子(1H)磁共振波谱模式的胰腺癌人工神经网络检测
  • DOI:
    10.1038/s43856-024-00727-0
  • 发表时间:
    2025-01-21
  • 期刊:
  • 影响因子:
    6.300
  • 作者:
    Meiyappan Solaiyappan;Santosh Kumar Bharti;Raj Kumar Sharma;Mohamad Dbouk;Wasay Nizam;Malcolm V. Brock;Michael G. Goggins;Zaver M. Bhujwalla
  • 通讯作者:
    Zaver M. Bhujwalla
Molecular and functional imaging insights into the role of hypoxia in cancer aggression
  • DOI:
    10.1007/s10555-019-09788-3
  • 发表时间:
    2019-03-06
  • 期刊:
  • 影响因子:
    8.700
  • 作者:
    Samata Kakkad;Balaji Krishnamachary;Desmond Jacob;Jesus Pacheco-Torres;Eibhlin Goggins;Santosh Kumar Bharti;Marie-France Penet;Zaver M. Bhujwalla
  • 通讯作者:
    Zaver M. Bhujwalla

Zaver M. Bhujwalla的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Zaver M. Bhujwalla', 18)}}的其他基金

The Tumor Microenvironment in Nanoparticle Delivery and Function
纳米颗粒递送和功能中的肿瘤微环境
  • 批准号:
    10059035
  • 财政年份:
    2020
  • 资助金额:
    $ 28.74万
  • 项目类别:
The Tumor Microenvironment in Nanoparticle Delivery and Function
纳米颗粒递送和功能中的肿瘤微环境
  • 批准号:
    10405098
  • 财政年份:
    2020
  • 资助金额:
    $ 28.74万
  • 项目类别:
The Tumor Microenvironment in Nanoparticle Delivery and Function
纳米颗粒递送和功能中的肿瘤微环境
  • 批准号:
    10170305
  • 财政年份:
    2020
  • 资助金额:
    $ 28.74万
  • 项目类别:
The Tumor Microenvironment in Nanoparticle Delivery and Function
纳米颗粒递送和功能中的肿瘤微环境
  • 批准号:
    10617333
  • 财政年份:
    2020
  • 资助金额:
    $ 28.74万
  • 项目类别:
Molecular Imaging and Theranostics of Cancer
癌症的分子成像和治疗诊断学
  • 批准号:
    10242814
  • 财政年份:
    2017
  • 资助金额:
    $ 28.74万
  • 项目类别:
Molecular Imaging and Theranostics of Cancer
癌症的分子成像和治疗诊断学
  • 批准号:
    10693873
  • 财政年份:
    2017
  • 资助金额:
    $ 28.74万
  • 项目类别:
Molecular Imaging Reagents for Prostate Cancer Theranostics
用于前列腺癌治疗诊断的分子成像试剂
  • 批准号:
    10226208
  • 财政年份:
    2017
  • 资助金额:
    $ 28.74万
  • 项目类别:
Molecular Imaging and Theranostics of Cancer
癌症的分子成像和治疗诊断学
  • 批准号:
    10455724
  • 财政年份:
    2017
  • 资助金额:
    $ 28.74万
  • 项目类别:
Molecular Imaging of Cachexia in Pancreatic Cancer
胰腺癌恶病质的分子影像
  • 批准号:
    9026680
  • 财政年份:
    2015
  • 资助金额:
    $ 28.74万
  • 项目类别:
Decoy nanoparticles to disrupt cancer cell-stromal cell networks
诱饵纳米颗粒破坏癌细胞-基质细胞网络
  • 批准号:
    9102034
  • 财政年份:
    2015
  • 资助金额:
    $ 28.74万
  • 项目类别:

相似海外基金

Mechanisms of Pro-Resolving Mediators in Periodontal Regeneration
牙周再生中促溶解介质的机制
  • 批准号:
    10764989
  • 财政年份:
    2023
  • 资助金额:
    $ 28.74万
  • 项目类别:
Oxidative Lipidomics in Pediatric Traumatic Brain Injury
氧化脂质组学在小儿创伤性脑损伤中的应用
  • 批准号:
    10844023
  • 财政年份:
    2023
  • 资助金额:
    $ 28.74万
  • 项目类别:
Resolution of inflammation and atrial fibrillation
炎症和心房颤动的解决
  • 批准号:
    10679718
  • 财政年份:
    2023
  • 资助金额:
    $ 28.74万
  • 项目类别:
Dissecting the Role of Arachidonic Acid Metabolic Pathways Involved in Resolution Versus Progression of PM-Induced Cardiometabolic Toxicity
剖析花生四烯酸代谢途径在 PM 诱导的心脏代谢毒性的消退与进展中的作用
  • 批准号:
    10716093
  • 财政年份:
    2023
  • 资助金额:
    $ 28.74万
  • 项目类别:
A Novel Neuroprotectant to Reduce Ischemic Injury
一种减少缺血性损伤的新型神经保护剂
  • 批准号:
    10576568
  • 财政年份:
    2023
  • 资助金额:
    $ 28.74万
  • 项目类别:
Lipid peroxidation- and pyroptosis-induced tissue factor activation in pathogen-induced blood coagulation
病原体诱导的血液凝固中脂质过氧化和焦亡诱导的组织因子激活
  • 批准号:
    10571353
  • 财政年份:
    2023
  • 资助金额:
    $ 28.74万
  • 项目类别:
Mechanisms regulating the biosynthesis and signaling of oxylipins
氧脂素生物合成和信号传导的调节机制
  • 批准号:
    10710733
  • 财政年份:
    2023
  • 资助金额:
    $ 28.74万
  • 项目类别:
Lipid Receptor GPR31 as a Target for Anti-Thrombotic and Stroke Therapy
脂质受体 GPR31 作为抗血栓和中风治疗的靶点
  • 批准号:
    10603440
  • 财政年份:
    2023
  • 资助金额:
    $ 28.74万
  • 项目类别:
Novel redox mechanisms of oxygenated phospholipids in chronic and diabetic kidney disease
慢性和糖尿病肾病中含氧磷脂的新氧化还原机制
  • 批准号:
    10752954
  • 财政年份:
    2023
  • 资助金额:
    $ 28.74万
  • 项目类别:
Glutathionylated Products of Radical-Induced Lipid Oxidation in Inflammatory Disease
炎症性疾病中自由基诱导的脂质氧化的谷胱甘肽化产物
  • 批准号:
    10736332
  • 财政年份:
    2023
  • 资助金额:
    $ 28.74万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了